Abstract
Outcome in SLE patients should include assessment of disease activity and chronic damage and also measurement of health-related quality of life and the economic impact of the disease. This paper reviews the methods available for doing this and the results of existing studies in SLE patients.
| Original language | English |
|---|---|
| Pages (from-to) | 645-54 |
| Number of pages | 10 |
| Journal | Lupus |
| Volume | 8 |
| Issue number | 8 |
| Publication status | Published - 1999 |
Keywords
- Anxiety
- Canada
- Clinical Trials as Topic
- Costs and Cost Analysis
- Depression
- Europe
- Fatigue
- Health Status
- Health Status Indicators
- Humans
- Lupus Erythematosus, Systemic
- Quality of Life
- Questionnaires
- Treatment Outcome